IL17 Rate and Spondyloarthritis

Abroad (travel likely)Recruiting

Conditions

Spondylarthritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de NICE, Nice, France
Contact: Study coordinator (Christian ROUX, Md, PhD) · roux.c2@chu-nice.fr · +33492035491
Contact: Study coordinator (Barbara SEITZ-POLSKI, MD, PhD) · seitz-polski.b@chu-nice.fr · +33492035990

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pain in Inflammatory Joint Diseases

Arthritis · Arthritis, Juvenile Idiopathic · Arthritis,Rheumatoid

Abroad (travel likely)Recruiting

Oslo, Norway

Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

Axial Spondylarthritis (axSpA) · Psoriatic Arthritis (PsA)

Abroad (travel likely)Recruiting

Bath, United Kingdom

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Rheumatic Diseases · Rheumatoid Arthritis (RA) · Giant Cell Arteritis (GCA)

Abroad (travel likely)Recruiting

Bonn, Germany

Observational Prospective Turkish Inception Cohort of Uveitis and Spondyloarthritis

Spondylarthritis · Uveitis, Anterior

Abroad (travel likely)Recruiting

Istanbul, Turkey (Türkiye)